Stay updated with breaking news from B Pfizer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
U.S. Surgeon General Vivek Murthy is assuring parents that regulators won't take shortcuts in authorizing a COVID-19 vaccine from Pfizer-BioNTech for kids younger than 5 as the Food and Drug Administration employs a two-step process to get a jump-start on the rollout.
U.S. Surgeon General Vivek Murthy is assuring parents that regulators won't take shortcuts in authorizing a COVID-19 vaccine from Pfizer-BioNTech for kids younger than 5 as the Food and Drug Administration employs a two-step process to get a jump-start on the rollout.
Pfizer and BioNTech are reportedly preparing to ask the Food and Drug Administration to authorize a COVID-19 vaccine for kids younger than 5.
U.S. regulators are planning to review and authorize Pfizer and BioNTech's COVID-19 vaccine for children younger than 5 before data on a third -- and potentially necessary -- shot is available.
U.S. regulators are urging drugmaker Pfizer to apply for emergency authorization for a two-dose regimen of its COVID-19 vaccine for children six months to 5 years old while awaiting data on a three-dose course, aiming to clear the way for the shots as soon as late February, a person familiar with the matter told The Associated Press Monday.